The global intravenous (IV) equipment market was valued at USD 18,774 million in 2024 and is forecasted to expand at a CAGR of 5.9%, reaching USD 35,270 million by 2035. This growth is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and heart conditions, which require prolonged intravenous therapy for drug administration, hydration, and nutritional support.

Technological advancements in IV equipment, including smart infusion pumps with wireless connectivity and data analytics, are enhancing safety and efficiency, reducing medical errors, and improving patient outcomes. The market's expansion is also supported by the growing demand for user-friendly, infection-preventing systems in healthcare settings worldwide.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7710

Market Segmentation and Trends:

The intravenous equipment market is segmented by type, end user, and region, providing a detailed analysis of its dynamics. Types include IV catheters, administration sets (solution and blood administration sets), infusion pumps, securement devices and check valves, drip chambers, needleless connectors, and other IV equipment. Infusion pumps and IV catheters dominate due to their critical role in precise medication delivery and vascular access. End users encompass hospitals, ambulatory surgical centers, clinics, and home care settings, with hospitals leading owing to high patient volumes and complex care needs.

Regionally, North America holds the largest share, while Asia Pacific is emerging rapidly due to healthcare infrastructure development. Trends include the adoption of AI-integrated smart pumps for real-time monitoring, eco-friendly disposable equipment to address medical waste, and wireless systems for seamless integration with electronic health records (EHRs).

Driving Factors Behind Market Growth

Key drivers of the intravenous equipment market include the rising incidence of chronic illnesses, with over 422 million people globally affected by diabetes and 19 million new cancer cases annually, necessitating advanced IV therapies. Technological innovations, such as AI-enabled infusion pumps that prevent dosing errors and enhance treatment accuracy, are propelling market growth.

Expanding healthcare infrastructure in developing economies, supported by initiatives like China's Healthy China 2030 Plan, is increasing access to quality medical services and boosting demand for IV equipment. Additionally, the focus on patient safety, with features like antimicrobial coatings on catheters to reduce infections, and the shift toward home-based care for cost-effective treatment, are further driving the market forward.

Recent Developments and Key Players:

The intravenous equipment market is competitive, with key players investing in R&D, product innovation, and strategic expansions. In January 2024, BD (Becton, Dickinson and Company) expanded its IV solutions portfolio by launching a next-generation closed IV catheter system designed to minimize bloodstream infections and enhance patient safety. In December 2023, B. Braun introduced a series of AI-integrated smart infusion pumps that connect with EHRs to improve medication delivery accuracy and reduce errors. Other notable developments include companies focusing on customized solutions to meet industry-specific needs and maintain competitiveness.

Major players include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein, Inc., Smiths Medical, Baxter International, Ascor S.A., Moog Inc., AngioDynamics, ICU Medical, Inc., Fresenius SE & Co. KGaA, Animas LLC, arcomed ag, International WIN, LTD., and The Metrix Company. These firms allocate significant revenue to R&D for innovative products, such as infection-preventing systems and user-friendly devices.

Competitor analysis shows a emphasis on sustainability and technological integration. Companies are developing eco-friendly IV equipment to address environmental concerns and comply with regulations. Strategic partnerships and acquisitions are common to enhance production capacity and technological capabilities, ensuring a strong market position in this evolving landscape.

Regional Insights and Opportunities:

North America dominates the intravenous equipment market, with the United States valued at USD 6,073.8 million in 2025 and projected to grow at a CAGR of 6.5% through 2035, driven by advanced healthcare systems and high chronic disease prevalence. Europe follows, benefiting from robust medical infrastructure and increasing adoption of smart IV technologies.

Asia Pacific, particularly China, is a high-growth region due to government initiatives like the Healthy China 2030 Plan, which aims to improve medical access and service quality. Emerging markets in Latin America and the Middle East & Africa present opportunities through expanding healthcare facilities and rising demand for affordable IV solutions. Partnerships with local distributors and investments in regional manufacturing are key to capitalizing on these growth areas.

Browse Full Report: https://www.factmr.com/report/intravenous-equipment-market

Challenges and Future Outlook:

The intravenous equipment market faces challenges, including the high cost of advanced IV systems, which limits adoption in resource-constrained settings, and the need for extensive training and maintenance. Regulatory hurdles and concerns over medical waste from disposable equipment also pose obstacles. However, the market's future is optimistic, with opportunities in sustainable, eco-friendly innovations and expansion into developing economies. Short-term growth (2025-2028) will be driven by technological advancements in wireless and analytics-enabled devices.

Medium-term (2029-2031) expansion will stem from healthcare infrastructure development, while long-term (2032-2035) focus will be on green solutions. As chronic diseases rise and technology evolves, the intravenous equipment market is poised for sustained growth, enhancing global healthcare delivery through efficient and safe IV therapies.